SCHEMBL14440320

SCHEMBL14440320

CCNc1ccc(NC(=O)c2ccc3ccccc3c2O)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLG P00747 2/20 0.67
KLK1 P06870 2/20 0.67
KLK6 Q92876 2/20 0.67
MEN1 O00255 8/20 0.60
KMT2A Q03164 8/20 0.60
POLB P06746 2/20 0.60
ALOX15 P16050 1/20 0.60
NPC1 O15118 4/20 0.59
RAB9A P51151 4/20 0.59
P2RX1 P51575 1/20 0.57
P2RX3 P56373 1/20 0.57
P2RX4 Q99571 1/20 0.57
P2RX7 Q99572 1/20 0.57
TNF P01375 2/20 0.54
NOD1 Q9Y239 2/20 0.54
MAPT P10636 2/20 0.54
LMNA P02545 1/20 0.54
DEGS1 O15121 1/20 0.54
KDM4E B2RXH2 1/20 0.53
ALDH1A1 P00352 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8438773 0.85 PLG (0.74) PLGKLK1KLK6MEN1KMT2A
SCHEMBL14428018 0.85 PLG (0.66) PLGKLK1KLK6MEN1KMT2A
SCHEMBL10336856 0.83 PLG (0.67) PLGKLK1KLK6MEN1KMT2A
SCHEMBL10885167 0.83 PLG (0.71) PLGKLK1KLK6MEN1KMT2A
SCHEMBL5383147 0.83 PLG (0.75) PLGKLK1KLK6MEN1KMT2A
SCHEMBL14112088 0.83 MEN1 (0.80) PLGKLK1KLK6MEN1KMT2A
SCHEMBL10888080 0.82 PLG (0.66) PLGKLK1KLK6MEN1KMT2A
SCHEMBL12305600 0.81 PLG (0.64) PLGKLK1KLK6MEN1KMT2A
SCHEMBL21273938 0.81 PLG (1.00) PLGKLK1KLK6MEN1KMT2A
Hydrochloric Acid SCHEMBL22798886 0.81 PLG (1.00) PLGKLK1KLK6MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070197533-A1 Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds ANADYS PHARMACEUTICALS, INC. (US) 2007-08-23 US disclosed
US-7223759-B2 Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds ANADYS PHARMACEUTICALS, INC. (US) 2007-05-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197533-A1 Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds DDC, DPP3, AMPD3 PLG 4709/4885KLK1 2917/4885KLK6 2107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.